Tejas Ahire: Rh Incompatibility – A Small Blood Group Difference with Big Clinical Impact
Tejas Ahire, Junior Officer in Downstream Process at Hetero Biopharma, shared a post on LinkedIn:
“Rh Incompatibility: A Small Blood Group Difference with Big Clinical Impact
Rh incompatibility occurs when an Rh-negative mother carries an Rh-positive fetus.
During pregnancy, the mother’s immune system may develop antibodies against fetal red blood cells, which can affect future Rh-positive pregnancies.
Key points:
- First pregnancy is usually unaffected
- IgG antibodies can cross the placenta
- May cause fetal anemia, jaundice, and severe complications
- Anti-D immunoglobulin is highly effective in prevention
Understanding this mechanism highlights the importance of antenatal screening and timely preventive care.
As healthcare professionals and students, knowing the science behind Rh incompatibility helps us appreciate how early intervention can save lives.
Did you know that a simple Anti-D injection can prevent most cases of Rh incompatibility?”
Stay updated with Hemostasis Today.
-
Jul 27, 2026, 03:34Wolfgang Miesbach: A Standout Talk by Jeffrey Weitz at ISTH 2026
-
Jul 26, 2026, 23:18Mohammadmahdi Sabahi: Proud to Share Our Complete Cushing’s Disease Research Collection
-
Jul 26, 2026, 22:59Mahmood Naseri: The Results of the 2nd Clinical Trial on AriClot Are Now Live in Burns Journal
-
Jul 26, 2026, 16:26Novi Yanti Sari: When MPNs Affect the Heart
-
Jul 26, 2026, 16:21Beyond Drugs: Can Museums Become a Medical Prescription?
-
Jul 26, 2026, 14:45Sarah Giorgia Grazia Giannone: An Exciting Chapter in Gene Therapy Research
-
Jul 26, 2026, 14:21Javed Anees: Cerebral Collateral Circulation in Acute Ischemic Stroke
-
Jul 26, 2026, 14:11André Picard։ Canadian Blood Supplies Drop Sharply, Urgent Donor Appeal Issued
-
Jul 26, 2026, 13:54Lorenzo Scalia: New Review Highlights Anticoagulant Strategies for Elderly Patients With Atrial Fibrillation